Dosidal · Switzerland
AREXVY, Pulver und Suspension zur Herstellung einer Injektionssuspension
Dosidal is a product record. It identifies a medicine and its regulatory status. It does not advise on use.
| Market | Switzerland |
|---|---|
| Record | ch:authorisation:69310 (version 1) |
| Level | authorisation |
| Pack code | not anchored |
| Identifiers | swissmedic-authorisation: 69310 atc: J07BX05 |
| Source authority | Swissmedic |
| Read date | |
| authorisation status | first_authorisation: 2024-05-02 term: zugelassen valid_until: 2029-05-01 state: current · read 2026-11-15T01:25:13Z · source: Swissmedic (OGD) page |
| identity | atc: J07BX05 authorisation_number: 69310 form: PULSIN holder: GlaxoSmithKline AG holder_partner_nr: 1000930 it_number: 08.08. name: AREXVY, Pulver und Suspension zur Herstellung einer Injektionssuspension state: current · read 2026-11-15T01:25:13Z · source: Swissmedic (OGD) page |
| Signature | ES256 over JCS, key dosidal-record-1.9dbf5d53O3Roiy9DOm5Oxb0mia3a98EqgRRhkThotJY3Li5x_Xq-l9gpYd-6-DZXz5UKZAQzcC9q8uKr96i4ys6cqFaP7QVerify with verify_record (MCP) or POST https://dosidal-api.ai/v1/verify/record; keyring https://dosidal-registry.ai/.well-known/jwks.json |